Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

The European LeukemiaNet: achievements and perspectives

Rüdiger Hehlmann et al. Haematologica. 2011 Jan.

Abstract

The only way to cure leukemia is by cooperative research. To optimize research, the European LeukemiaNet integrates 105 national leukemia trial groups and networks, 105 interdisciplinary partner groups and about 1,000 leukemia specialists from 175 institutions. They care for tens of thousands of leukemia patients in 33 countries across Europe. Their ultimate goal is to cure leukemia. Since its inception in 2002, the European LeukemiaNet has steadily expanded and has unified leukemia research across Europe. The European LeukemiaNet grew from two major roots: 1) the German Competence Network on Acute and Chronic Leukemias; and 2) the collaboration of European Investigators on Chronic Myeloid Leukemia. The European LeukemiaNet has improved leukemia research and management across Europe. Its concept has led to funding by the European Commission as a network of excellence. Other sources (European Science Foundation; European LeukemiaNet-Foundation) will take over when the support of the European Commission ends.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Participants of the European LeukemiaNet according to their location. According to the rules of the European Commission, only institutions can be participants. One participating institution may comprise more than one leukemia trial or interdisciplinary partner group. Participating institutions are listed in the Online Supplementary Appendix.
Figure 2.
Figure 2.
Working-groups and organigram of the European LeukemiaNet.
See this image and copyright information in PMC

References

    1. Hehlmann R, Berger U, Aul C, Büchner T, Döhner H, Ehninger G, et al. The German competence network ‘Acute and chronic leukemias’. Leukemia. 2004;18(4):665–9. - PubMed
    1. Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al. Evolving concepts in the management of chronic myeloid leukemia. Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006;108(6):1809–20. - PubMed
    1. Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia. Lancet. 2007;370:342–50. - PubMed
    1. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009;27(35):6041–51. - PMC - PubMed
    1. Müller MC, Cross NC, Erben P, Schenk T, Hanfstein B, Ernst T, et al. Harmonization of molecular monitoring of CML therapy in Europe. Leukemia. 2009;23(11):1957–63. - PubMed

Publication types

MeSH terms